|
![]() |
||||||||||||||||||||||||||||||||||||||||||||
|
![]() |
||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Source: E. coli strain containing an overproducing clone of E. coli Exonuclease I. | |||||||||||||||||||||||||||||||||||||||||||||
Applications:
| |||||||||||||||||||||||||||||||||||||||||||||
Description: Exonuclease I is particularly useful in preparing the products of PCR for applications involving sequencing or labeling methods(3). Typically, the excess primers and any other extraneous single-stranded DNA present in PCR products will interfere with subsequent enzymatic reactions involving DNA synthesis. The hydrolytic properties of Exonuclease I degrade all single-stranded DNA present in the PCR mixture allowing the product to be used more efficiently in other applications. When combined with Shrimp Alkaline Phosphatase (PN 70092) for dNTP dephosphorylation, the use of alternative purification methods, such as columns, gels or magnetic separations, are completely eliminated. For PCR clean up with Exonuclease I, see the ExoSAP-IT protocol. The purchase of ExoSAP-IT provides a license to the methods of PCR clean up using Exonuclease I and SAP. | |||||||||||||||||||||||||||||||||||||||||||||
Properties: Purity: Storage Buffer: Assay Conditions: Unit Definition: Concentration: References:
| |||||||||||||||||||||||||||||||||||||||||||||
Storage: | |||||||||||||||||||||||||||||||||||||||||||||





5' direction, releasing 